All Stories

  1. Identification of a seasonal influenza vaccine–induced broadly protective neuraminidase antibody

    Article • Journal of Experimental Medicine, April 2025, Rockefeller University Press

    Nisreen Okba

  2. Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

    Article • Nature Communications, July 2022, Springer Science + Business Media

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  3. Experimental and field investigations of exposure, replication and transmission of SARS-CoV-2 in pigs in the Netherlands

    Article • Emerging Microbes & Infections, November 2021, Taylor & Francis

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  4. Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients

    Article • Journal of Clinical Investigation, September 2021, American Society for Clinical Investigation

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  5. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

    Article • Proceedings of the National Academy of Sciences, June 2021, Proceedings of the National Academy of Sciences

    Gerd Sutter, Professor (Associate) Bart L. Haagmans, Nisreen Okba

  6. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

    Article • Nature Communications, May 2021, Springer Science + Business Media

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  7. SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

    Article • The Journal of Infectious Diseases, May 2021, Oxford University Press (OUP)

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  8. A Single Subcutaneous or Intranasal Immunization with Adenovirus‐Based SARS‐CoV‐2 Vaccine Induces Robust Humoral and Cellular Immune Responses in Mice

    Article • European Journal of Immunology, March 2021, Wiley

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  9. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

    Article • Nature Communications, March 2021, Springer Science + Business Media

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  10. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

    Article • Nature Communications, January 2021, Springer Science + Business Media

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  11. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccination

    Article • January 2021, Cold Spring Harbor Laboratory Press

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  12. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

    Article • Cell, January 2021, Elsevier

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  13. Susceptibility of rabbits to SARS-CoV-2

    Article • Emerging Microbes & Infections, December 2020, Taylor & Francis

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  14. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

    Article • November 2020, Cold Spring Harbor Laboratory Press

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  15. Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  16. Susceptibility of rabbits to SARS-CoV-2

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  17. Homologous and heterologous antibodies to coronavirus 229E, NL63, OC43, HKU1, SARS, MERS and SARS-CoV-2 antigens in an age stratified cross-sectional serosurvey in a large tertiary hospital in The Netherlands

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  18. SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  19. SARS-CoV-2 is transmitted via contact and via the air between ferrets

    Article • Nature Communications, July 2020, Springer Science + Business Media

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  20. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

    Article • Nature Communications, July 2020, Springer Science + Business Media

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  21. Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease 2019 Patients

    Article • Emerging Infectious Diseases, July 2020, Centers for Disease Control and Prevention (CDC)

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  22. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

    Article • Science Immunology, June 2020, American Association for the Advancement of Science

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  23. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

    Article • Science, June 2020, American Association for the Advancement of Science

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  24. Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection

    Article • Nature Communications, May 2020, Springer Science + Business Media

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  25. A human monoclonal antibody blocking SARS-CoV-2 infection

    Article • Nature Communications, May 2020, Springer Science + Business Media

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  26. Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies

    Article • Emerging Infectious Diseases, May 2020, Centers for Disease Control and Prevention (CDC)

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  27. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

    Article • Science, April 2020, American Association for the Advancement of Science

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  28. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Seropositive Camel Handlers in Kenya

    Article • Viruses, April 2020, MDPI AG

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  29. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

    Article • The Lancet Infectious Diseases, April 2020, Elsevier

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  30. A human monoclonal antibody blocking SARS-CoV-2 infection

    Article • March 2020, Cold Spring Harbor Laboratory Press

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  31. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV

    Article • Emerging Microbes & Infections, January 2020, Taylor & Francis

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  32. MERS-CoV in Camels but Not Camel Handlers, Sudan, 2015 and 2017

    Article • Emerging Infectious Diseases, December 2019, Centers for Disease Control and Prevention (CDC)

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  33. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections

    Article • Emerging Infectious Diseases, October 2019, Centers for Disease Control and Prevention (CDC)

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  34. Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus

    Article • Emerging Infectious Diseases, October 2019, Centers for Disease Control and Prevention (CDC)

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  35. Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors

    Article • Journal of Virology, June 2019, ASM Journals

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  36. Lack of Middle East Respiratory Syndrome Coronavirus Transmission in Rabbits

    Article • Viruses, April 2019, MDPI AG

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  37. Zika Virus Infection Induces Elevation of Tissue Factor Production and Apoptosis on Human Umbilical Vein Endothelial Cells

    Article • Frontiers in Microbiology, April 2019, Frontiers

    Nisreen Okba

  38. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein

    Article • Emerging Microbes & Infections, January 2019, Taylor & Francis

    Professor (Associate) Bart L. Haagmans, Nisreen Okba, Stalin Raj VICTOR, Francisco Javier Gutierrez Alvarez, Yiping Rong

  39. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein

    Article • Emerging Microbes & Infections, January 2019, Taylor & Francis

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  40. Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection

    Article • Science Advances, August 2018, American Association for the Advancement of Science

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  41. Middle East respiratory syndrome coronavirus specific antibodies in naturally exposed Israeli llamas, alpacas and camels

    Article • One Health, May 2018, Elsevier

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  42. MERS-coronavirus: From discovery to intervention

    Article • One Health, June 2017, Elsevier

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  43. Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches

    Article • Current Opinion in Virology, April 2017, Elsevier

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  44. A poxvirus-based vaccine reduces virus excretion after MERS coronavirus infection in dromedary camels

    Article • International Journal of Infectious Diseases, April 2016, Elsevier

    Professor (Associate) Bart L. Haagmans, Nisreen Okba

  45. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

    Article • Science, December 2015, American Association for the Advancement of Science

    Professor (Associate) Bart L. Haagmans, Nisreen Okba